These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16918312)

  • 1. Pharmacokinetics of recombinant human endostatin in rats.
    Yang XX; Hu ZP; Chan E; Duan W; Zhou S
    Curr Drug Metab; 2006 Aug; 7(6):565-76. PubMed ID: 16918312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in rats.
    Li ZG; Jia L; Guo LF; Yu M; Sun X; Nie W; Fu Y; Rao CM; Wang JZ; Luo YZ
    Acta Pharmacol Sin; 2015 Jul; 36(7):847-54. PubMed ID: 26027657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of recombinant human endostatin in patients with advanced solid tumors.
    Herbst RS; Hess KR; Tran HT; Tseng JE; Mullani NA; Charnsangavej C; Madden T; Davis DW; McConkey DJ; O'Reilly MS; Ellis LM; Pluda J; Hong WK; Abbruzzese JL
    J Clin Oncol; 2002 Sep; 20(18):3792-803. PubMed ID: 12228199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys.
    Song HF; Liu XW; Zhang HN; Zhu BZ; Yuan SJ; Liu SY; Tang ZM
    Acta Pharmacol Sin; 2005 Jan; 26(1):124-8. PubMed ID: 15659125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance and Pharmacokinetics of Recombinant Human Endostatin Administered as Single-Dose or Multiple-Dose Infusions in Patients With Advanced Solid Tumors: A Phase I Clinical Trial.
    Wang X; Shi Y; Jia Y; Zhao W; Zhang L; Bai G; Ren Y; Chen YZ; Tong Z
    Technol Cancer Res Treat; 2021; 20():15330338211064434. PubMed ID: 34931914
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.
    Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):403-10. PubMed ID: 9842984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys.
    Guo L; Li Z; Xu B; Yu M; Fu Y; Liu L; Wang J; Luo Y
    Life Sci; 2019 Dec; 238():116967. PubMed ID: 31626794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
    Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M
    Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of a tumour-targeting therapy candidate rh-IFNα2a-NGR with rh-IFNα2a administered intravenously in mice and rats.
    Wang XX; Lu L; Song CL; Qian WN; Zhang SY; Zhang YQ; Wu YJ
    J Pharm Pharmacol; 2013 Apr; 65(4):574-81. PubMed ID: 23488787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.
    Hu Z; Niu H; Yang X; Li H; Sang G; Li B
    Int J Pharm; 2006 Jul; 317(2):144-54. PubMed ID: 16621369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.
    Salmon J; Coussediere D; Cousty C; Raynaud JP
    J Steroid Biochem; 1983 Aug; 19(2):1223-34. PubMed ID: 6887930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, distribution, metabolism and excretion of.
    Yasoshima K; Kuwabara T; Fuse E; Kuramitu T; Kurata N; Nishiie H; Oishi T; Kobayashi H; Kobayashi S
    Cancer Chemother Pharmacol; 2001; 47(2):106-12. PubMed ID: 11269735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, tissue distribution and excretion of recombinant human parathyroid hormone 1-84 in animals.
    Bai H; Jing D; Jiang H; Yin S
    Cell Biochem Biophys; 2013 Jun; 66(2):379-87. PubMed ID: 23314825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.
    Tachibana S; Fujimaki Y; Tachibana M; Tanaka M; Kurata T; Okazaki O; Sudo K
    Arzneimittelforschung; 2005; 55(3):135-44. PubMed ID: 15819385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of an ultra-performance liquid chromatography method with tandem mass spectrometry to pharmacokinetics, tissue distribution and excretion in the study of DAT-230, a novel tubulin-binding agent candidate, in rats.
    Tang J; Zhang C; Sun J; Zhao L; Zhang W; Liu Z; Sun L; Chen X
    J Pharm Biomed Anal; 2015 Jun; 110():49-57. PubMed ID: 25800882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.